Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Prof. Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Prof. Dr. (MD, MPH, PhD) at MarmaraÜniversitesi, Turkey

Prof. Dr. Ayşe Nilüfer (Gülersoy) Özaydın is a distinguished academic and public health expert with a career spanning over four decades. Born in Eskişehir, Turkey in 1959, she has contributed extensively to the fields of epidemiology, cancer prevention, reproductive health, and health education. She currently serves as a Professor in the Department of Public Health at Marmara University School of Medicine, Istanbul. Her vast experience includes roles as a guest lecturer at several medical schools, both in Turkey and Cyprus, and she has held key leadership positions in national health organizations and academic committees. Prof. Özaydın is a recognized figure in public health circles for her advocacy and pioneering work in breast cancer awareness and prevention. With numerous national and international affiliations, including WHO and GFMER, she has established herself as a thought leader and changemaker. Her work bridges clinical research, health policy, and education, impacting both public health systems and academic communities.

Professional Profile

Education

Prof. Dr. Özaydın’s academic journey began with a medical degree from Hacettepe University in 1984, followed by a master’s and Ph.D. in Public Health at the same institution. She further enhanced her expertise with postgraduate studies in Epidemiology and Statistics at the Liverpool School of Tropical Medicine in the UK. Over the years, she pursued a wide array of certifications in areas such as health education, reproductive health, clinical research methods, occupational health, and medical education, reflecting her commitment to lifelong learning and multidisciplinary expertise. She has completed advanced training courses at globally recognized institutions including Johns Hopkins University and the University of Maastricht. Her education is not only marked by academic degrees but by continuous professional development, particularly in emerging areas like cancer bioinformatics and qualitative research methods. This robust educational foundation has been critical in shaping her holistic and proactive approach to public health challenges in both academic and policy-making settings.

Professional Experience

Prof. Dr. Özaydın has accumulated extensive professional experience across clinical, academic, and governmental health sectors since beginning her career in 1984. She has worked as a physician in various public health centers across Turkey, assuming critical roles in immunization campaigns and women’s health services. Transitioning into academia, she joined Marmara University’s School of Medicine, where she advanced from lecturer to full professor in the Department of Public Health. Alongside her academic roles, she has served as a guest faculty member at institutions like Eastern Mediterranean University, Near East University, and Okan University. Her leadership includes appointments to advisory boards of the Turkish Ministry of Health, WHO initiatives, and national health strategy groups. In addition, she has held presidencies at key organizations such as the Breast Health Society (MEMEDER) and the Marmara Health Education and Research Foundation (MARSEV). Her professional record reflects deep engagement in both health system strengthening and medical education innovation.

Research Interest

Prof. Özaydın’s research interests are rooted in public health and focus extensively on breast cancer prevention, screening practices, and public awareness strategies. She is also deeply engaged in studies surrounding sexual and reproductive health, family planning, sexually transmitted infections, immunization programs, and occupational diseases. Her interdisciplinary approach merges clinical epidemiology with health education and behavior change communication. She has led and contributed to prevalence surveys, curriculum development projects, and national screening programs. Recently, she has explored newer research avenues like cancer bioinformatics and health-related social determinants in medical students. Her work is characterized by its direct impact on public health policy and community health improvement, with a particular emphasis on underserved populations. Prof. Özaydın’s research not only informs academic literature but also translates into practical guidelines and strategic plans for health ministries and global health bodies. Her studies are frequently published in peer-reviewed journals and presented at major international conferences.

Awards and Honors

Throughout her illustrious career, Prof. Özaydın has received numerous honors and appointments recognizing her academic and professional contributions. She is a valued member of the WHO Global Breast Cancer Initiative and has been invited to serve on scientific and advisory boards for Turkey’s Ministry of Health, including strategic task forces on cancer epidemiology and reproductive health. She was appointed president of MEMEDER and MARSEV, reflecting her leadership in health advocacy and education. Her contributions have been instrumental in developing national strategies for HIV/AIDS, family planning, and cancer screening. She has represented Turkey in multiple international collaborations and training programs, and her coordination role for the Geneva Foundation for Medical Education and Research highlights her global influence. Though specific award titles are not listed, her numerous appointments, leadership roles, and committee memberships across prestigious health and academic institutions serve as strong testaments to her recognition and esteem in the medical and scientific community.

Conclusion

Dr. Özaydın is a highly accomplished researcher with a distinguished career in public health, medical education, and epidemiology. Her expertise in areas like breast cancer prevention and reproductive health, along with her international collaborations and publications, positions her as a strong candidate for the Best Researcher Award. With a focus on expanding her interdisciplinary efforts and enhancing the global reach of her research, Dr. Özaydın’s contributions could be even more impactful in the future.

Publications Top Notes

  • Prevalence and risk factors of Helicobacter pylori in Turkey
    ➤ Authors: N. Özaydın, S.A. Turkyilmaz, S. Cali
    ➤ Citations: 264

  • Erkeklerde Cinsel Mitlere İnanma Oranları ve Mitlere İnanmayı Etkileyen Faktörler
    ➤Authors: F. Torun, S.D. Torun, A.N. Özaydın
    ➤ Citations: 127

  • Effect of extremely low frequency electromagnetic fields on growth rate and morphology of bacteria
    ➤ Authors: A. Inhan-Garip, B. Aksu, Z. Akan, D. Akakin, A.N. Özaydın, T. San
    ➤ Citations: 120

  • Assessment of sociodemographic and economic factors affecting immunization services in Istanbul
    ➤ Authors: H.H. Topuzoglu, A. Özaydın, G.A. Cali, D. Cebeci, S. Kalaca
    ➤ Citations: 102

  • Bahçeşehir’de oturan kadınların meme kanseri bilgi düzeyleri ve uygulamaları
    ➤ Authors: A.N. Özaydın, B.M. Güllüoğlu, P.C. Ünalan, S. Gorpe, B.R. Öner, et al.
    ➤ Citations: 71

  • Survey on a mammographic screening program in Istanbul
    ➤ Authors: V. Özmen, A.N. Özaydın, N. Cabioglu, B.M. Gulluoglu, P.C. Unalan, et al.
    ➤ Citations: 59

  • Türkiye’de evli erkeklerin aile planlaması yöntemlerini kullanmalarını etkileyen faktörler
    ➤Authors: L. Akın, N. Özaydın, D. Aslan
    ➤ Citations: 57

  • Sources of breast cancer knowledge and screening attendance – Moda, Istanbul
    ➤ Authors: A. Yildirim, A. Özaydın
    ➤ Citations: 50

  • Isotretinoin has no negative effect on attention, executive function and mood
    ➤ Authors: T. Ergun, D. Seckin, N. Özaydın, Ö. Bakar, A. Comert, et al.
    ➤ Citations: 47

  • Meme Kanserinde Tarama ve Tanı (İstanbul Konsensus Konferansı)
    ➤ Authors: S. Baskan, K. Atahan, E. Arıbal, N. Özaydın, P. Balcı, E. Yavuz
    ➤ Citations: 44

  • Cost-effectiveness of breast cancer screening in Turkey
    ➤ Authors: V. Özmen, S.Ö. Gürdal, N. Cabioğlu, B. Özcinar, A.N. Özaydın, et al.
    ➤ Citations: 38

  • Successful first round results of a Turkish breast cancer screening program
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, N. Cabioglu, E. Ozturk, et al.
    ➤ Citations: 34

  • Diagnostic performance of AI for cancers in a mammography screening program
    ➤ Authors: I. Kizildag Yirgin, Y.O. Koyluoglu, M.E. Seker, S. Ozkan Gurdal, A.N. Özaydın, et al.
    ➤ Citations: 26

  • Dijital yerlilerin gözünden dijital okuryazarlık
    ➤ Authors: A. Özaydın, O. Kumral
    ➤ Citations: 23

  • The relationship between males’ attitudes to partner violence and contraception
    ➤ Authors: L. Akin, N. Özaydın
    ➤ Citations: 23

  • Kadın ve şiddet
    ➤ Authors: N. Özaydın, O. Üner, A. Akın
    ➤ Citations: 23

  • Bahçeşehir Meme Kanseri Tarama Projesi İlk Dönem Sonuçları
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, E. Öztürk, N. Cabıoğlu, E. Arıbal
    ➤ Citations: 20

  • Care burden among informal caregivers of ALS patients
    ➤ Authors: Z. Tülek, A. Özakgül, N. Alankaya, A. Dik, A. Kaya, P.C. Ünalan, A.N. Özaydın, et al.
    ➤ Citations: 16

  • İstanbul/Moda’da kadınların meme kanseri bilgisi ve tarama katılımı
    ➤ Authors: A. Demir Yıldırım, A. Nilüfer Özaydın
    ➤ Citations: 16

  • İstenmeyen gebelikler ve düşüklerin kadın sağlığına etkileri
    ➤ Authors:  N. Özaydın, A. Akın
    ➤ Citations: 15

 

Alexander Kirichenko | Health Professions | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Alexander Kirichenko | Health Professions | Best Researcher Award

Professor Drexel University College of Medicine Drexellat at Allegheny General Hospital, United States

Dr. Alexander V. Kirichenko, MD, PhD, is a distinguished radiation oncologist and researcher with extensive expertise in stereotactic body radiotherapy (SBRT) and radiation biology. He currently serves as an Attending Radiation Oncologist at Allegheny General Hospital and System Director for Stereotactic Body Radiotherapy & Gastrointestinal Cancers Program at Allegheny Health Network Cancer Institute. With a career spanning over four decades, Dr. Kirichenko has made significant contributions to oncology research, particularly in hepatocellular carcinoma and functional treatment planning. His humanitarian efforts include leading international collaborations to advance radiation oncology care in Ukraine. A dedicated educator and innovator, Dr. Kirichenko has contributed to multiple clinical trials, patents, and book chapters, shaping the future of radiation oncology.

Professional Profile

Education

Dr. Kirichenko earned his MD from Kyiv Medical University, Ukraine, in 1981, followed by a residency in Radiation Oncology and Nuclear Medicine. He later obtained a PhD in Radiation Biology and a D.Sc. in Radiation Medicine. In pursuit of advanced training, he completed a postdoctoral fellowship at MD Anderson Cancer Center and obtained U.S. medical licensure from the University of Virginia. His residency training in General Surgery and Radiation Oncology at the University of Virginia further solidified his expertise. These rigorous academic and clinical experiences have enabled him to excel in both patient care and research.

Professional Experience

With a career dedicated to radiation oncology, Dr. Kirichenko has held various prestigious academic and clinical positions. He served as an Associate Professor at the Ukrainian National Cancer Institute and the University of Virginia before joining Allegheny General Hospital in 2006. As a leading expert, he has been involved in the development of advanced radiation therapies, including SBRT for liver malignancies. His work also extends to international collaborations, where he has played a pivotal role in enhancing global cancer care standards. His leadership within multiple healthcare institutions has made a lasting impact on cancer treatment methodologies.

Research Interests

Dr. Kirichenko’s research primarily focuses on radiation-induced toxicity, functional treatment planning, and advanced imaging techniques in radiation therapy. His studies on SBRT for hepatocellular carcinoma have contributed to improving survival outcomes while minimizing toxicity. He has also explored the use of superparamagnetic iron oxide nanoparticles (SPION) for enhancing MRI-guided radiotherapy. Through his involvement in numerous clinical trials and NIH-funded studies, he has pioneered innovative approaches in liver and rectal cancer treatment. His research continues to influence clinical practices, bridging the gap between experimental oncology and patient-centered care.

Awards and Honors

Throughout his career, Dr. Kirichenko has received numerous accolades for his contributions to radiation oncology. He has been recognized as one of the Best Doctors in America (2013–2023) and has received the Health Care Heroes Award from Pittsburgh Business Times. His leadership in national and international oncology projects has earned him appointments to expert panels, including the National Center for Biosecurity and Biodefense Preparedness. His extensive list of invited lectures, patents, and book chapters further reflects his commitment to advancing cancer research and treatment.

Conclusion

Dr. Alexander V. Kirichenko is a highly qualified and impactful researcher in radiation oncology with strong contributions to clinical innovation, translational research, and international collaboration. His extensive body of work, patents, leadership roles, and humanitarian contributions make him a strong candidate for the Best Researcher Award. If supplemented with further high-impact publications, mentorship initiatives, and policy engagements, his profile would be nearly unbeatable.

Publications Top Notes

  • Title: Chronomodulated chemotherapy and irradiation: An idea whose time has come?

  • Authors:

    • Tyvin A. Rich

    • Charles H. Shelton III

    • Alexander V. Kirichenko

    • Martin Straume

  • Journal: Chronobiology International

  • Year of Publication: 2002

  • Citations: 18 (as per available sources)